MAPT and Alzheimer disease: Other recent studies also showed an increase of NFAT-1 in a different transgenic AD mouse model63, and a third proteopathy for AD, suggests that an alteration of the scaffolding protein FILAMIN-A, is critically linked to the amyloid and tau pathologies in AD and leads to increased tau phosphorylation64.